AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
#412 - An RFK Intervention (w/ Coleman Hughes)
The Fifth Column
The Incentive to Innovate in Normal Times
In normal times, the principal knock on the regulators who are responsible for approving drugs is that they take entirely too long. But in general, the rest of the pharmaceutical industry actually doesn't have a great deal of incentive to innovate because it's really, really hard to get your drugs approved. The principle victim there and the principle consequence is that lots of people end up dying because the experimental drugs that might have saved their life don't ever get released. And that's the real cost.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode